Novo Nordisk A/S
Novo Nordisk A/S (NONOF) Stock Overview
Explore Novo Nordisk A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
196.6B
P/E Ratio
10.50
EPS (TTM)
$4.30
ROE
0.66%
NONOF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Novo Nordisk A/S (NONOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 57.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.50 and a market capitalization of 196.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.